Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.23 - $0.46 $4,676 - $9,353
-20,333 Reduced 5.93%
322,700 $85,000
Q1 2022

May 16, 2022

BUY
$0.3 - $0.61 $1,800 - $3,660
6,000 Added 1.78%
343,033 $147,000
Q4 2021

Feb 14, 2022

BUY
$0.55 - $1.04 $101,420 - $191,776
184,400 Added 120.81%
337,033 $185,000
Q2 2021

Aug 16, 2021

SELL
$1.22 - $1.65 $41,114 - $55,605
-33,700 Reduced 18.09%
152,633 $230,000
Q1 2021

May 17, 2021

SELL
$1.18 - $2.62 $43,095 - $95,687
-36,522 Reduced 16.39%
186,333 $287,000
Q4 2020

Feb 16, 2021

BUY
$1.05 - $2.24 $233,997 - $499,195
222,855 New
222,855 $234,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.